14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
The long wait is over. Today, the U.S. Department of Labor confirmed the final rule on the overtime ...
Read More >
There’s some surprise market wheeling and dealing afoot this morning. The Hong Kong stock exchange ...
Read More >
The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquir...
Read More >
When does title to goods transfer from a contractor to an employer? This can be a critical issue, es...
Read More >
If an employment contract is illegal for some reason both the employer and employee may be prevented...
Read More >
On July 30, 2020, the Committee on Foreign Investment in the United States (CFIUS or the Committee) ...
Read More >